CurveBeam AI Future Growth
Future criteria checks 2/6
CurveBeam AI is forecast to grow earnings and revenue by 46.7% and 45.9% per annum respectively. EPS is expected to grow by 55.5% per annum. Return on equity is forecast to be -22% in 3 years.
Key information
46.7%
Earnings growth rate
55.5%
EPS growth rate
| Medical Equipment earnings growth | 16.2% |
| Revenue growth rate | 45.9% |
| Future return on equity | -22.0% |
| Analyst coverage | Low |
| Last updated | 11 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 6/30/2027 | 35 | -4 | -1 | -1 | 1 |
| 6/30/2026 | 27 | -9 | -8 | -8 | 1 |
| 6/30/2025 | 15 | -18 | -6 | -5 | 1 |
| 6/30/2024 | 7 | -23 | -22 | -22 | N/A |
| 3/31/2024 | 8 | -40 | -24 | -24 | N/A |
| 12/31/2023 | 9 | -57 | -26 | -26 | N/A |
| 9/30/2023 | 9 | -54 | -24 | -24 | N/A |
| 6/30/2023 | 8 | -51 | -23 | -22 | N/A |
| 3/31/2023 | 5 | -33 | -18 | -17 | N/A |
| 12/31/2022 | 1 | -14 | -13 | -13 | N/A |
| 9/30/2022 | 1 | -11 | -11 | -11 | N/A |
| 6/30/2022 | N/A | -9 | -8 | -8 | N/A |
| 6/30/2021 | 1 | -3 | -2 | -2 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CVB is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: CVB is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: CVB is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: CVB's revenue (45.9% per year) is forecast to grow faster than the Australian market (5.8% per year).
High Growth Revenue: CVB's revenue (45.9% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: CVB is forecast to be unprofitable in 3 years.